









Title: Neurodevelopmental outcomes at one year in offspring of mothers who test positive for SARS- 
CoV-2 during pregnancy 




1. Department of Obstetrics and Gynecology, Massachusetts General Hospital and Harvard Medical 
School, Boston, MA. 
2. Center for Quantitative Health and Department of Psychiatry, Massachusetts General Hospital and 
Harvard Medical School, Boston, MA. 

Roy H. Perlis 
Department of Psychiatry 
Massachusetts General Hospital 
Simches Research Building 
185 Cambridge St 
Boston, MA 02114 
rperlis@mgh.harvard.edu 
(617) 726-7426 

ords: 2481 
Abstract: 249 
Tables: 2 
Figures: 1 
Supplemental Materials: 1 






















 
 
 
 


















































 
 
 

































 








































































































 


































 









































































































 

















 
 
 




















 
 
 














Maternal age, Median (IQR) 
Maternal race, n (%) 
Asian 
Black or African American 
Other 
Unknown 
White 
Hispanic 
Not Hispanic 
Unavailable 
Maternal public insurance, n (%) 
Trimester of maternal SARS-COV-2 infection, n (%) 
1st 
2nd 
3rd 
Unknown 
Maternal gestational diabetes, n (%) 
Maternal pre-eclampsia, n (%) 
Maternal hemorrhage, n (%) 
Delivery hospital type, n (%) 
Academic medical center 
Community hospital 
Delivery method, n (%) 
C-Section 
Vaginal 
Multiple births, n (%) 
Delivery admission length of stay (days), Median (IQR) 
Pre-term birth, n (%) 
Preterm 
Term 
Female 
Male 
Pregnancy SARS- 
COV-2 Negative, 
N = 7,550 
33.0 (30.0 – 36.0) 
Pregnancy SARS- 
COV-2 Positive, 
N = 222 
31.0 (26.2 – 35.0) 
<0.001 
<0.001 
765 (10) 
617 (8.2) 
657 (8.7) 
230 (3.0) 
5,281 (70) 
1,019 (13) 
6,283 (83) 
248 (3.3) 
1,297 (17) 
0 (NA) 
0 (NA) 
0 (NA) 
7,550 
1,025 (14) 
1,398 (19) 
1,512 (20) 
4,383 (58) 
3,167 (42) 
7 (3.2) 
39 (18) 
76 (34) 
18 (8.1) 
82 (37) 
115 (52) 
95 (43) 
12 (5.4) 
134 (60) 
1 (0.5) 
61 (27) 
160 (72) 
0 
38 (17) 
43 (19) 
41 (18) 
165 (74) 
57 (26) 
2,423 (32) 
5,127 (68) 
292 (3.9) 
3.00 (2.00 – 3.00) 
70 (32) 
152 (68) 
14 (6.3) 
3.00 (2.00 – 3.00) 
654 (8.7) 
6,896 (91) 
32 (14) 
190 (86) 
3,714 (49) 
3,836 (51) 
39.29 (38.43 – 40.14) 
2 
3,345 (3,015 – 3,655) 
55 
20.00 (19.00 – 20.50) 
244 
8.00 (8.00 – 9.00) 
9.00 (9.00 – 9.00) 
105 (47) 
117 (53) 
39.14 (37.71 – 40.11) 
0 
3,257 (2,895 – 3,544) 
4 
19.50 (19.00 – 20.08) 
15 
8.00 (8.00 – 8.00) 
9.00 (9.00 – 9.00) 
<0.001 
NA 
0.13 
0.75 
0.57 
<0.001 
0.066 
0.85 
0.003 
0.052 
0.85 
Offspring 1-min. APGAR score, Median (IQR) 
Offspring 5-min. APGAR score, Median (IQR) 
1Wilcoxon rank sum test; Pearson's Chi-squared test; Fisher's exact test 


 
 
 
 
 
 
 

 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 

 
 

 
 



 



 



 
 













 
 
 













F82 
F80.1 
F80.9 
F89 
F88 
F80.2 
F81.9 
F80.0 
F80.4 
Specific developmental disorder of motor function 
Expressive language disorder 
Developmental disorder of speech and language, unspecified 
Unspecified disorder of psychological development 
Other disorders of psychological development 
Mixed receptive-expressive language disorder 
Developmental disorder of scholastic skills, unspecified 
Phonological disorder 
Speech and language development delay due to hearing loss 
Pregnancy 
SARS-COV-2 
Negative, 
N = 7,550 
99 
53 
48 
39 
8 
<5 
<5 
<5 
<5 
Pregnancy 
SARS-COV-2 
Positive, 
N = 222 
6 
<5* 
7 
0 
<5 
0 
0 
0 
0 
* cell counts less than 5 are replaced with ‘<5’ to minimize risk of re-identifiability, per institutional 
protocol. Columns totals exceed number of affected offspring because an individual may have more 
than one diagnosis. 
ICD-10-CM 
code 



